Sweden· SE-20190628000101
Suxinutin 50 mg/ml Oral lösning
A medicinal product containing ethosuximide, registered in Sweden by Orifarm AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Ethosuximide
- Manufacturer
- Orifarm AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20190628000101
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ethosuximide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesEthosuximideMylan Pharmaceuticals Inc.
- NorwayPetnidanDesitin
- United KingdomEmeside 250mg capsulesFontus Health Ltd
- GermanyEthosuximid GlenmarkGlenmark Arzneimittel Gmbh
- IrelandZarontin 250 mg/5 ml SyrupEssential Pharma (M) Limited
- CanadaMAR-ETHOSUXIMIDEMARCAN PHARMACEUTICALS INC
- NetherlandsEthosuximide Strides 250 mg zachte capsulesStrides Pharma (Cyprus) Limited
- CzechiaPETINIMIDG.L. Pharma GmbH, Lannach
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Ethosuximid Neuraxpharm, Petinimid
- Belgium · Zarontin
- Bulgaria · Petinimid
- Czechia · Petinimid
- Germany · Ethosuximid Glenmark, Ethosuximid Neuraxpharm
- Denmark · Ethosuximide Orifarm, Ethosuximide Strides
- Spain · Etosuximida Faes
- France · Zarontin
- United Kingdom (Northern Ireland) · Emeside, Epesri
- Croatia · Suxital
- Ireland · Zarontin
- Italy · Etosuccimide Glenmark, Zarontin
- Luxembourg · Zarontin
- Netherlands · Ethosuximide Aurobindo, Ethosuximide Strides
- Norway · Ethosuximide Orifarm, Ethosuximide Strides
- Poland · Petinimid
- Slovenia · Suxital
- Slovakia · Petinimid Cps, Petnidan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e81fe1a7-b68b-4649-b08b-20facbedb060 GET /v1/drugs/e81fe1a7-b68b-4649-b08b-20facbedb060?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20190628000101",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190628000101",
"product_doc_link": "https://docetp.mpa.se/LMF/Suxinutin%2050%20mg%20per%20ml%20oral%20solution%20IT%20PL_09001bee80d73f08.pdf"
}See everything about ethosuximide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.